Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,339,000 | 2,566,000 | 1,514,000 | 714,000 | 2,004,000 |
| Depreciation Amortization | 977,000 | 727,000 | 468,000 | 235,000 | 908,000 |
| Income taxes - deferred | -199,000 | -79,000 | 6,000 | N/A | -140,000 |
| Accounts receivable | 55,000 | N/A | N/A | N/A | -150,000 |
| Other Working Capital | -253,000 | -274,000 | -217,000 | -85,000 | 445,000 |
| Other Operating Activity | 217,000 | 94,000 | 69,000 | 22,000 | 306,000 |
| Operating Cash Flow | $4,136,000 | $3,034,000 | $1,840,000 | $886,000 | $3,373,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -710,000 | 183,000 | 284,000 | -97,000 | -719,000 |
| Net Acquisitions | -4,951,000 | -4,962,000 | N/A | N/A | 0 |
| Purchase Of Investment | -436,000 | -415,000 | -400,000 | -221,000 | -433,000 |
| Other Investing Activity | 642,000 | -45,000 | -23,000 | -10,000 | 236,000 |
| Investing Cash Flow | $-5,455,000 | $-5,239,000 | $-139,000 | $-328,000 | $-916,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 626,000 | 971,000 | -16,000 | -18,000 | -2,002,000 |
| Debt Issued | 2,537,000 | 2,536,000 | 2,535,000 | N/A | 445,000 |
| Debt Repayment | -2,017,000 | -2,013,000 | -975,000 | -72,000 | -325,000 |
| Common Stock Issued | 180,000 | 137,000 | 125,000 | 72,000 | 169,000 |
| Common Stock Repurchased | -99,000 | N/A | N/A | N/A | N/A |
| Dividend Paid | -668,000 | -496,000 | -329,000 | -165,000 | -528,000 |
| Other Financing Activity | 14,000 | 11,000 | 10,000 | 8,000 | -24,000 |
| Financing Cash Flow | $573,000 | $1,146,000 | $1,350,000 | $-175,000 | $-2,265,000 |
| Exchange Rate Effect | -1,000 | -1,000 | -192,000 | -22,000 | -51,000 |
| Beginning Cash Position | 1,995,000 | 1,995,000 | 1,995,000 | 1,995,000 | 1,854,000 |
| End Cash Position | 1,248,000 | 935,000 | 4,854,000 | 2,356,000 | 1,995,000 |
| Net Cash Flow | $-747,000 | $-1,060,000 | $2,859,000 | $361,000 | $141,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,136,000 | 3,034,000 | 1,840,000 | 886,000 | 3,373,000 |
| Capital Expenditure | -710,000 | -476,000 | -301,000 | -165,000 | -719,000 |
| Free Cash Flow | 3,426,000 | 2,558,000 | 1,539,000 | 721,000 | 2,654,000 |